share_log

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Marinus Pharmicals、Neumora Therapeutics和其他大股在周一的盘前交易中走低
Benzinga ·  04/15 08:19

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.

今天上午美国股票期货走高,道琼斯指数期货周一上涨超过200点。

Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) fell sharply in today's pre-market trading after the company issued an update on the Phase 3 RAISE Trial and reported preliminary first quarter 2024 financial results.

Marinus Pharmicals, Inc.(纳斯达克股票代码:MRNS)的股价在今天的盘前交易中大幅下跌,此前该公司发布了第三阶段RAISE试验的最新情况,并公布了2024年第一季度的初步财务业绩。

Marinus Pharma reported Prelim ZTALMY (Ganaxolone) net product revenue of $7.4 million to $7.6 million for the first quarter.

Marinus Pharma报告称,第一季度Prelim ZTALMY(Ganaxolone)的净产品收入为740万至760万美元。

Marinus Pharmaceuticals shares dipped 74.2% to $1.94in pre-market trading.

Marinus Pharmicals的股价在盘前交易中下跌了74.2%,至1.94美元。

Here are some big stocks recording losses in today's pre-market trading session.

以下是一些在今天的盘前交易时段中录得亏损的大型股票。

  • Neumora Therapeutics, Inc. (NASDAQ:NMRA) shares declined 17.1% to $11.25 pre-market trading after the FDA placed a clinical hold on the company's Phase 1 NMRA-266 study.
  • Roadzen, Inc. (NASDAQ:RDZN) shares fell 14% to $5.04 in pre-market trading.
  • Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares fell 11.4% to $41.64 in pre-market trading after the company disclosed interim Phase 1/2 data in patients with angelman syndrome after treatment with GTX-102.
  • Cogent Biosciences, Inc. (NASDAQ:COGT) shares declined 7.7% to $6.01 in pre-market trading. Cogent Biosciences recently reported preclinical data from CNS-Penetrant ErbB2 Inhibitor Program.
  • Polestar Automotive Holding UK PLC (NASDAQ:PSNY) shares fell 7.2% to $1.35 in pre-market trading.
  • Molina Healthcare, Inc. (NYSE:MOH) shares fell 7.1% to $350.00 in pre-market trading.
  • TORM plc (NASDAQ:TRMD) shares slipped 3.1% to $32.92 in pre-market trading.
  • Neumora Therapeutics, Inc.(纳斯达克股票代码:NMRA)股价在盘前交易中下跌17.1%,至11.25美元,此前美国食品药品管理局对该公司的1期 NMRA-266 研究进行了临床搁置。
  • 路森公司(纳斯达克股票代码:RDZN)股价在盘前交易中下跌14%,至5.04美元。
  • Ultragenyx Pharmaceutical Inc.(纳斯达克股票代码:RARE)股价在盘前交易中下跌11.4%,至41.64美元,此前该公司披露了 GTX-102 治疗后的天使综合征患者的1/2期中期数据。
  • Cogent Biosciences, Inc.(纳斯达克股票代码:COGT)股价在盘前交易中下跌7.7%,至6.01美元。Cogent Biosciences最近报告了来自CNS渗透剂eRbB2抑制剂计划的临床前数据。
  • 英国极星汽车控股有限公司(纳斯达克股票代码:PSNY)股价在盘前交易中下跌7.2%,至1.35美元。
  • 莫利纳医疗保健公司(纽约证券交易所代码:MOH)股价在盘前交易中下跌7.1%,至350.00美元。
  • TORM plc(纳斯达克股票代码:TRMD)股价在盘前交易中下跌3.1%,至32.92美元。

Now Read This: Top 3 Tech Stocks That May Explode This Month

现在读这个: 本月可能爆发的三大科技股

Don't forget to check out our premarket coverage here

别忘了在这里查看我们的上市前报道

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发